A Safety and Immunogenicity Study of Heterologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants
Clinical trial NCT02313077 · COMPLETED
Trial details
- NCT number
- NCT02313077
- Sponsor
- Crucell Holland BV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-17
- Primary completion
- 2015-04-17
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.